Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
21-Aug-2025 | 712 | 716 | 694 | 698.35 | 11,697 | 17,07,96,051.9 | 1,17,240 |
22-Aug-2025 | 698 | 737.85 | 692 | 724.25 | 29,693 | 54,59,38,779 | 2,81,819 |
25-Aug-2025 | 729.5 | 735 | 715.1 | 717.85 | 14,055 | 17,48,55,839.2 | 1,15,354 |
26-Aug-2025 | 720 | 725.9 | 703.35 | 707.25 | 14,836 | 21,18,72,863.4 | 83,986 |
28-Aug-2025 | 707.25 | 709.2 | 688.3 | 697.95 | 19,866 | 20,63,27,469.45 | 1,55,069 |
29-Aug-2025 | 697.95 | 712.65 | 675 | 690.15 | 20,851 | 18,31,98,949.2 | 1,15,243 |
01-Sep-2025 | 690.15 | 717 | 690.15 | 701.65 | 10,640 | 11,97,76,875 | 80,607 |
02-Sep-2025 | 708.85 | 709.5 | 692.1 | 696.5 | 7,142 | 9,75,46,478.25 | 77,091 |
03-Sep-2025 | 693 | 716.9 | 692 | 712.7 | 12,224 | 14,95,61,305.4 | 88,169 |
04-Sep-2025 | 712.7 | 725.55 | 701.15 | 704.05 | 8,503 | 10,50,46,656.5 | 75,394 |
05-Sep-2025 | 704 | 732 | 700.15 | 719.15 | 14,486 | 16,93,56,534.95 | 1,01,153 |
08-Sep-2025 | 721.05 | 748.5 | 714 | 745.35 | 13,065 | 21,98,85,446.25 | 1,79,205 |
09-Sep-2025 | 745.1 | 751.2 | 726.25 | 736.45 | 14,221 | 18,39,12,244.1 | 1,17,609 |
10-Sep-2025 | 737 | 738 | 705.3 | 718.9 | 14,659 | 19,91,83,359.35 | 1,38,725 |
11-Sep-2025 | 725 | 727.95 | 705.15 | 708.4 | 9,103 | 8,64,23,760.95 | 59,136 |
12-Sep-2025 | 712.1 | 722.95 | 681 | 689.9 | 17,820 | 25,36,78,403.2 | 1,64,936 |
15-Sep-2025 | 689.5 | 694.45 | 681 | 683.85 | 9,871 | 11,90,60,669.35 | 84,719 |
16-Sep-2025 | 695 | 699 | 682.1 | 686.5 | 10,062 | 12,11,69,673.25 | 89,432 |
17-Sep-2025 | 689 | 696.25 | 683 | 689.25 | 7,064 | 9,94,03,477.85 | 78,718 |
18-Sep-2025 | 693 | 719 | 687.65 | 716.15 | 14,247 | 24,69,20,216.85 | 1,66,436 |
19-Sep-2025 | 717.4 | 722.7 | 705.2 | 712.3 | 7,888 | 12,65,11,270.7 | 95,204 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
